Financiado en parte por Johnson and Johnson, Johnson & Johnson /Society for the Arts and Healthcare
AIR: Advances in Respiration - Music therapy in the treatment of chronic pulmonary disease
Canga B, Azoulay R, Raskin J, Loewy J
Respiratory medicine · 28 citas
Etiquetas de revisión
Financiado por la industriaDatos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.
Cómo se estudió
- Diseño
- Ensayo controlado aleatorizado (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiado por la industria
- Empresa
- Johnson and Johnson
- Empresa
- Johnson & Johnson /Society for the Arts and Healthcare
Según 2 financiadores declarados.
Publicación
- Publicado
- 2015-10-23 · Respir Med · vol. 109 · número 12 · págs. 1532–1539
- Editorial
- Elsevier BV
- Citado
- 77 citas · más que el 92% de estudios similares · 3.7× el promedio de su campo
- Impacto
- Entre el 10 % más citado de su campo
- Referencias
- 39 trabajos
- Acceso
- Lectura gratuita
- Áreas de investigación
- Music Therapy and Health · Chronic Obstructive Pulmonary Disease (COPD) Research · Music Education and Analysis
- Palabras clave
- music therapy, chronic obstructive pulmonary disease, pulmonary rehabilitation, depression, dyspnea, quality of life, psychological well-being, lung disease, singing, music visualization
- MeSH
- humans, pulmonary disease, chronic obstructive, dyspnea, fatigue, treatment outcome, music therapy, depressive disorder, quality of life, adult, aged, aged, 80 and over, middle aged, female, male
4 autores
- Bernardo Canga🇺🇸 · autor de correspondenciaMount Sinai Beth Israel
- Ronit Azoulay🇺🇸Mount Sinai Beth Israel
- Jonathan M. Raskin🇺🇸Mount Sinai Beth Israel
- Joanne V. Loewy🇺🇸Mount Sinai Beth Israel
Resumen
El texto original del estudio, en el idioma en que se publicó.
The aim of this randomized control study is to examine the effect of a multimodal psycho-music therapy intervention on respiratory symptoms, psychological well-being and quality of life of patients with Chronic Obstructive Pulmonary Disease and other lung diseases as adjunct to Pulmonary Rehabilitation with a design of music therapy plus PR compared to Pulmonary Rehabilitation alone. Music therapy group treatment including music visualization, wind playing and singing was provided weekly. This was compared with standard care treatment. Adults ages 48 to 88 (mean 70.1) with moderate to severe GOLD stage II-IV lung disease as well as other diseases processes that lead to chronic airflow limitations were included (n = 98). Participants in both conditions were followed from baseline enrollment to six weeks post control/treatment. Outcome measures included the Beck Depression Inventory Scale 2nd edition-Fast Screen (BDI-FS), Chronic Respiratory Questionnaire Self-Reported (CRQ-SR), and Dyspnea Visual Analog Scale (VAS). Results showed improvement in symptoms of depression (LS mean -0.2) in the music therapy group with statistical divergence between groups (p = 0.007). The CRQ-SR demonstrated improvement in dyspnea (p = 0.01 LS mean 0.5) and mastery (p = 0.06 LS mean 0.5) in the music therapy group and fatigue (p = 0.01 LS mean 0.3). VAS demonstrated highly significant effect in the music therapy group between weeks 5 and 6 (p < 0.001). The findings of this study suggest that music therapy combined with standard PR may prove to be an effective modality in the management of pulmonary disease.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.